eFFECTOR Therapeutics, Inc.
EFTR$51M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaSOLANA BEACH
Drugs in Pipeline
4
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
EFTR News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
Tomivosertib
Non-small Cell Lung Cancer
eFT508
Microsatellite Stable Relapsed or Refractory Colorectal Cancer
Tomivosertib (eFT-508)
Solid Tumors
eFT226
Solid Tumor, Adult
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Tomivosertib | Phase 2 | Non-small Cell Lung Cancer | - | - |
eFT508 | Phase 2 | Microsatellite Stable Relapsed or Refractory Colorectal Cancer | - | - |
Tomivosertib (eFT-508) | Phase 2 | Solid Tumors | - | - |
eFT226 | Phase 2 | Solid Tumor, Adult | - | - |
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply